These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30658442)

  • 1. Modulation of the Endocannabinoid System Following Central Nervous System Injury.
    Zhou J; Noori H; Burkovskiy I; Lafreniere JD; Kelly MEM; Lehmann C
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microcirculatory Changes in Experimental Models of Stroke and CNS-Injury Induced Immunodepression.
    Lunardi Baccetto S; Lehmann C
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Immune Response to Traumatic CNS Injuries-Are Extracellular Vesicles the Missing Link?
    Yates AG; Anthony DC; Ruitenberg MJ; Couch Y
    Front Immunol; 2019; 10():2723. PubMed ID: 31824504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Cannabinoid 2 Receptor Modulation on the Peripheral Immune Response in Central Nervous System Injury-Induced Immunodeficiency Syndrome.
    Sultana S; Burkovskiy I; Zhou J; Kelly MM; Lehmann C
    Cannabis Cannabinoid Res; 2021 Aug; 6(4):327-339. PubMed ID: 33998888
    [No Abstract]   [Full Text] [Related]  

  • 5. Toll-like receptor 4 in CNS pathologies.
    Buchanan MM; Hutchinson M; Watkins LR; Yin H
    J Neurochem; 2010 Jul; 114(1):13-27. PubMed ID: 20402965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid system: a new entry in remote cell death mechanisms.
    Viscomi MT; Oddi S; Latini L; Bisicchia E; Maccarrone M; Molinari M
    Exp Neurol; 2010 Jul; 224(1):56-65. PubMed ID: 20353775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders.
    Sharma DS; Paddibhatla I; Raghuwanshi S; Malleswarapu M; Sangeeth A; Kovuru N; Dahariya S; Gautam DK; Pallepati A; Gutti RK
    J Neuroimmunol; 2021 Apr; 353():577501. PubMed ID: 33571815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease.
    Tanasescu R; Gran B; Constantinescu CS
    Amino Acids; 2013 Jul; 45(1):95-112. PubMed ID: 22367605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
    Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome.
    Burkovskiy I; Zhou J; Lehmann C
    Microcirculation; 2016 May; 23(4):283-92. PubMed ID: 26999797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome.
    Lehmann C; Burkovskiy I; Kuethe J; Zhou J; Caldwell C; Kelly ME
    Med Hypotheses; 2014 Jun; 82(6):736-9. PubMed ID: 24702836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Surveillance of the CNS following Infection and Injury.
    Russo MV; McGavern DB
    Trends Immunol; 2015 Oct; 36(10):637-650. PubMed ID: 26431941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders.
    Zhou K; Shi L; Wang Y; Chen S; Zhang J
    J Immunol Res; 2016; 2016():9238290. PubMed ID: 27652274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation.
    Zhou J; Burkovskiy I; Yang H; Sardinha J; Lehmann C
    Front Pharmacol; 2016; 7():264. PubMed ID: 27597829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.
    Correa F; Hernangómez-Herrero M; Mestre L; Loría F; Docagne F; Guaza C
    Brain Behav Immun; 2011 May; 25(4):736-49. PubMed ID: 21310228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Endocannabinoid System as a Potential Therapeutic Target for HIV-1-Associated Neurocognitive Disorder.
    Chu L; Shu Z; Gu X; Wu Y; Yang J; Deng H
    Cannabis Cannabinoid Res; 2023 Jun; 8(3):445-463. PubMed ID: 36745405
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.
    Sun Y; Wen Y; Wang L; Wen L; You W; Wei S; Mao L; Wang H; Chen Z; Yang X
    Front Immunol; 2021; 12():654626. PubMed ID: 34079543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.
    Chicca A; Arena C; Manera C
    Recent Pat CNS Drug Discov; 2016; 10(2):122-141. PubMed ID: 27630088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition.
    Papa A; Pasquini S; Contri C; Gemma S; Campiani G; Butini S; Varani K; Vincenzi F
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders.
    Bisogno T; Di Marzo V
    Pharmacol Res; 2007 Nov; 56(5):428-42. PubMed ID: 17933549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.